Propylthiouracil-induced agranulocytosis: an unusual presentation and a possible mechanism.

[1]  R. Meyboom,et al.  Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells , 1986, British journal of haematology.

[2]  R. Van Der Stadt,et al.  Thrombocytopenia associated with gold therapy: a drug‐induced autoimmune disease? , 1986, British journal of haematology.

[3]  M. Lobell,et al.  Ibuprofen-associated pure white-cell aplasia. , 1986, The New England journal of medicine.

[4]  R. Kaaja,et al.  [Agranulocytosis induced by antithyroid drugs]. , 1986, Duodecim; laaketieteellinen aikakauskirja.

[5]  M. Miyakawa,et al.  Graves’ disease with neutropenia and marked splenomegaly: autoimmune neutropenia due to propylthiouracil , 1985, Journal of endocrinological investigation.

[6]  Burns Cp,et al.  Granulocytotoxic antibodies in a patient with propylthiouracil-induced agranulocytosis. , 1984 .

[7]  J. Dunn.  Choice of therapy in young adults with hyperthyroidism of Graves' disease. A brief, case-directed poll of fifty-four thyroidologists. , 1984, Annals of internal medicine.

[8]  L. Braverman,et al.  In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis. , 1984, The Journal of clinical endocrinology and metabolism.

[9]  J. Wolfsdorf,et al.  An anti‐neutrophil antibody associated with a propylthiouracil‐induced lupus‐like syndrome , 1983, Transfusion.

[10]  P. Ladenson,et al.  Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. , 1983, Annals of internal medicine.

[11]  O. Shemesh,et al.  Transient methimazole-induced bone marrow aplasia: in vitro evidence for a humoral mechanism of bone marrow suppression. , 1983, Acta haematologica.

[12]  F. Pacini,et al.  Multiple complications of propylthiouracil treatment: granulocytopenia, eosinophilia, skin reaction and hepatitis with lymphocyte sensitization , 1982, Journal of endocrinological investigation.

[13]  E. Greenspan.  Clinical interpretation and practice of cancer chemotherapy , 1982 .

[14]  W. Tyler,et al.  Propylthiouracil-induced cutaneous vasculitis. Case presentation and review of the literature. , 1980, JAMA.

[15]  N. Smith.  Acute stomatitis medicamentosa. Two case reports. , 1978, Australian dental journal.

[16]  S. Weitzman,et al.  DRUG-INDUCED IMMUNOLOGICAL NEUTROPENIA , 1978, The Lancet.

[17]  R. Blizzard,et al.  Antithyroid drug therapy for toxic diffuse goiter (Graves disease): thirty years experience in children and adolescents. , 1977, The Journal of pediatrics.

[18]  M. Rosove.  Agranulocytosis and antithyroid drugs. , 1977, The Western journal of medicine.

[19]  P. McIntyre,et al.  Immunological: reactions involving leukocytes: III. Agranulocytosis induced by antithyroid drugs. , 1976, The Johns Hopkins medical journal.

[20]  N. Rose,et al.  Manual of clinical immunology , 1976 .

[21]  Pisciotta Av.  Immune and toxic mechanisms in drug-induced agranulocytosis. , 1973 .

[22]  J. Rasmussen.  CASE PRESENTATION AND REVIEW OF THE LITERATURE , 1973 .

[23]  H. Wagner,et al.  Evidence for anti-leukocyte antibodies as a mechanism for drug-induced agranulocytosis. , 1971, Transactions of the Association of American Physicians.

[24]  F. Kenny,et al.  Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy. , 1970, The Journal of pediatrics.

[25]  R. Siegel,et al.  Combined median and ulnar nerve lesions complicating fractures of the distal radius and ulna. Two case reports. , 1968 .

[26]  A. Yunis,et al.  Bone marrow aplasia following propylthiouracil therapy. Report of a case with complete recovery. , 1967, Archives of internal medicine.

[27]  J. Dacie,et al.  Autoimmune haemolytic anaemia associated with alpha-methyldopa therapy. , 1966 .

[28]  J. Einbinder,et al.  Immunoleukopenia as an aspect of hypersensitivity to Propylthiouracil. , 1963, JAMA.